Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -164.82% is 145% below its 5-year average of -67.25%, near the high end of its 5-year range (-2182.35%–17.48%).
4815.56% below its 12-month average of 3.50%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 17.48%.
NET PROFIT MARGIN
-164.82%
NET PROFIT MARGIN AVG TTM
3.50%
NET PROFIT MARGIN AVG 3Y
-18.61%
NET PROFIT MARGIN AVG 5Y
-67.25%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-4815.56%
CURRENT VS 3Y AVG
-785.63%
CURRENT VS 5Y AVG
-145.09%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 764 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Werewolf Therapeutics, Inc.
Market Cap
$45.42M
Net Profit Margin
-164.82%
TTM Avg
3.50%
3Y Avg
-18.61%
5Y Avg
-67.25%
Market Cap
$45.37M
Net Profit Margin
322.77%
TTM Avg
-172.32%
3Y Avg
-215.38%
5Y Avg
-270.73%
Market Cap
$44.69M
Net Profit Margin
-84.93%
TTM Avg
-105.50%
3Y Avg
-125.06%
5Y Avg
-177.30%
Market Cap
$44.31M
Net Profit Margin
-145.56%
TTM Avg
-153.73%
3Y Avg
-223.84%
5Y Avg
-240.41%
Market Cap
$43.85M
Net Profit Margin
-747.20%
TTM Avg
-525.22%
3Y Avg
-722.73%
5Y Avg
-1271.67%
Market Cap
$43.04M
Net Profit Margin
32.60%
TTM Avg
-34.66%
3Y Avg
-64.33%
5Y Avg
-204.90%
Market Cap
$47.83M
Net Profit Margin
-11.51%
TTM Avg
-20.89%
3Y Avg
-14.48%
5Y Avg
-10.80%
Market Cap
$42.36M
Net Profit Margin
-13.86%
TTM Avg
-1.65%
3Y Avg
-39.69%
5Y Avg
-47.80%
Market Cap
$41.92M
Net Profit Margin
-4.42%
TTM Avg
-14.19%
3Y Avg
-49.13%
5Y Avg
-77.93%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Werewolf Therapeutics, Inc. (HOWL) | $45.42M | -164.82% | 3.50% | -18.61% | -67.25% |
| DarioHealth Corp. (DRIO)vs › | $45.37M | 322.77% | -172.32% | -215.38% | -270.73% |
| CVRx, Inc. (CVRX)vs › | $44.69M | -84.93% | -105.50% | -125.06% | -177.30% |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $44.31M | -145.56% | -153.73% | -223.84% | -240.41% |
| Nano-X Imaging Ltd. (NNOX)vs › | $43.85M | -747.20% | -525.22% | -722.73% | -1271.67% |
| SANUWAVE Health Inc. (SNWV)vs › | $43.04M | 32.60% | -34.66% | -64.33% | -204.90% |
| Precision Optics Corporation, Inc. (POCI)vs › | $47.83M | -11.51% | -20.89% | -14.48% | -10.80% |
| BioStem Technologies, Inc. (BSEM)vs › | $42.36M | -13.86% | -1.65% | -39.69% | -47.80% |
| Precipio, Inc. (PRPO)vs › | $41.92M | -4.42% | -14.19% | -49.13% | -77.93% |
| Lite Strategy, Inc. (LITS)vs › | $49.00M | 0.00% | 0.00% | -9.50% | -48.42% |
Operating Margin
0.0%
Net Profit Margin
-164.8%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 17.48% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | -1509.10% |
| 2024-03-31 | -2182.35% |
| 2023-12-31 | -799.67% |
| 2023-09-30 | -140.50% |
| 2023-06-30 | -63.09% |
| 2023-03-31 | -268.41% |
| 2022-12-31 | -163.81% |
| 2022-09-30 | -240.30% |
| 2022-06-30 | -351.83% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
